Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.

Ashek A, Spruijt OA, Harms HJ, Lammertsma AA, Cupitt J, Dubois O, Wharton J, Dabral S, Pullamsetti SS, Huisman MC, Frings V, Boellaard R, de Man FS, Botros L, Jansen S, Vonk Noordegraaf A, Wilkins MR, Bogaard HJ, Zhao L.

Circ Cardiovasc Imaging. 2018 Aug;11(8):e007402. doi: 10.1161/CIRCIMAGING.117.007402.

PMID:
30354494
2.

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR, Baras A, Sampson KJ, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Church C, Coghlan G, Corris PA, Eyries M, Gibbs JSR, Girerd B, Houweling AC, Humbert M, Guignabert C, Kiely DG, Lawrie A, MacKenzie Ross RV, Martin JM, Montani D, Peacock AJ, Pepke-Zaba J, Soubrier F, Suntharalingam J, Toshner M, Treacy CM, Trembath RC, Vonk Noordegraaf A, Wharton J, Wilkins MR, Wort SJ, Yates K, Gräf S, Morrell NW, Krishnan U, Rosenzweig EB, Shen Y, Nichols CG, Kass RS, Chung WK.

Circ Genom Precis Med. 2018 Oct;11(10):e002087. doi: 10.1161/CIRCGEN.118.002087.

PMID:
30354297
3.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.

Delcroix M, Staehler G, Gall H, Grünig E, Held M, Halank M, Klose H, Vonk-Noordegraaf A, Rosenkranz S, Pepke-Zaba J, Opitz CF, Gibbs JSR, Lange TJ, Tsangaris I, Huscher D, Pittrow D, Olsson KM, Hoeper MM.

Eur Respir J. 2018 Nov 8;52(5). pii: 1800248. doi: 10.1183/13993003.00248-2018. Print 2018 Nov.

PMID:
30337446
4.

Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Lahm T, Douglas IS, Archer SL, Bogaard HJ, Chesler NC, Haddad F, Hemnes AR, Kawut SM, Kline JA, Kolb TM, Mathai SC, Mercier O, Michelakis ED, Naeije R, Tuder RM, Ventetuolo CE, Vieillard-Baron A, Voelkel NF, Vonk-Noordegraaf A, Hassoun PM; American Thoracic Society Assembly on Pulmonary Circulation.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):e15-e43. doi: 10.1164/rccm.201806-1160ST.

PMID:
30109950
5.

Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Ende-Verhaar YM, van den Hout WB, Bogaard HJ, Meijboom LJ, Huisman MV, Symersky P, Vonk-Noordegraaf A, Klok FA.

J Thromb Haemost. 2018 Nov;16(11):2168-2174. doi: 10.1111/jth.14266. Epub 2018 Aug 30.

PMID:
30099844
6.

Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodeling unaltered in experimental pulmonary hypertension.

Rol N, de Raaf MA, Sun X, Kuiper VP, da Silva Gonçalves Bos D, Happé C, Kurakula K, Dickhoff C, Thuillet R, Tu L, Guignabert C, Schalij I, Lodder K, Pan X, Herrmann FE, van Nieuw Amerongen GP, Koolwijk P, Vonk-Noordegraaf A, de Man FS, Wollin L, Goumans MJ, Szulcek R, Bogaard HJ.

Cardiovasc Res. 2018 Jul 18. doi: 10.1093/cvr/cvy186. [Epub ahead of print]

PMID:
30032282
7.

Pulmonary embolism.

Huisman MV, Barco S, Cannegieter SC, Le Gal G, Konstantinides SV, Reitsma PH, Rodger M, Vonk Noordegraaf A, Klok FA.

Nat Rev Dis Primers. 2018 May 17;4:18028. doi: 10.1038/nrdp.2018.28. Review.

PMID:
29770793
8.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension.

Gräf S, Haimel M, Bleda M, Hadinnapola C, Southgate L, Li W, Hodgson J, Liu B, Salmon RM, Southwood M, Machado RD, Martin JM, Treacy CM, Yates K, Daugherty LC, Shamardina O, Whitehorn D, Holden S, Aldred M, Bogaard HJ, Church C, Coghlan G, Condliffe R, Corris PA, Danesino C, Eyries M, Gall H, Ghio S, Ghofrani HA, Gibbs JSR, Girerd B, Houweling AC, Howard L, Humbert M, Kiely DG, Kovacs G, MacKenzie Ross RV, Moledina S, Montani D, Newnham M, Olschewski A, Olschewski H, Peacock AJ, Pepke-Zaba J, Prokopenko I, Rhodes CJ, Scelsi L, Seeger W, Soubrier F, Stein DF, Suntharalingam J, Swietlik EM, Toshner MR, van Heel DA, Vonk Noordegraaf A, Waisfisz Q, Wharton J, Wort SJ, Ouwehand WH, Soranzo N, Lawrie A, Upton PD, Wilkins MR, Trembath RC, Morrell NW.

Nat Commun. 2018 Apr 12;9(1):1416. doi: 10.1038/s41467-018-03672-4.

9.

A Rare Hemodynamic Cause of Airway Obstruction.

Tramper J, Vonk Noordegraaf A, Meijboom LJ, Zwitserloot AM, Straver B, Aman J.

Am J Respir Crit Care Med. 2018 May 1;197(9):e20-e21. doi: 10.1164/rccm.201709-1830IM. No abstract available.

PMID:
29505270
10.

The success of pulmonary hypertension treatment: improved cardiac function by reducing the arterial load.

Vonk-Noordegraaf A, Westerhof BE.

Pulm Circ. 2018 Jan-Mar;8(1):2045894018761632. doi: 10.1177/2045894018761632. No abstract available.

11.

Effectiveness of an internet-based perioperative care programme to enhance postoperative recovery in gynaecological patients: cluster controlled trial with randomised stepped-wedge implementation.

Bouwsma EVA, Huirne JAF, van de Ven PM, Vonk Noordegraaf A, Schaafsma FG, Schraffordt Koops SE, van Kesteren PJM, Brölmann HAM, Anema JR.

BMJ Open. 2018 Jan 30;8(1):e017781. doi: 10.1136/bmjopen-2017-017781.

12.

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.

Zelniker TA, Huscher D, Vonk-Noordegraaf A, Ewert R, Lange TJ, Klose H, Dumitrescu D, Halank M, Held M, Gall H, Pittrow D, Hoeper MM, Frankenstein L.

Clin Res Cardiol. 2018 Jun;107(6):460-470. doi: 10.1007/s00392-018-1207-5. Epub 2018 Jan 24.

PMID:
29368137
13.

Dasatinib increases endothelial permeability leading to pleural effusion.

Phan C, Jutant EM, Tu L, Thuillet R, Seferian A, Montani D, Huertas A, Bezu JV, Breijer F, Vonk Noordegraaf A, Humbert M, Aman J, Guignabert C.

Eur Respir J. 2018 Jan 18;51(1). pii: 1701096. doi: 10.1183/13993003.01096-2017. Print 2018 Jan.

PMID:
29348177
14.

Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.

Tramper J, Nossent EJ, Lely RJ, Krouwels FH, Meijboom LJ, Vonk Noordegraaf A.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701502. doi: 10.1183/13993003.01502-2017. Print 2018 Jan. No abstract available.

PMID:
29326329
15.

Using patient data to optimize an expert-based guideline on convalescence recommendations after gynecological surgery: a prospective cohort study.

Bouwsma EVA, Anema JR, Vonk Noordegraaf A, de Vet HCW, Huirne JAF.

BMC Surg. 2017 Dec 6;17(1):129. doi: 10.1186/s12893-017-0317-8.

16.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise.

Kovacs G, Herve P, Barbera JA, Chaouat A, Chemla D, Condliffe R, Garcia G, Grünig E, Howard L, Humbert M, Lau E, Laveneziana P, Lewis GD, Naeije R, Peacock A, Rosenkranz S, Saggar R, Ulrich S, Vizza D, Vonk Noordegraaf A, Olschewski H.

Eur Respir J. 2017 Nov 22;50(5). pii: 1700578. doi: 10.1183/13993003.00578-2017. Print 2017 Nov. Erratum in: Eur Respir J. 2018 Jan 18;51(1):.

PMID:
29167297
17.

Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

da Silva Gonçalves Bós D, Van Der Bruggen CEE, Kurakula K, Sun XQ, Casali KR, Casali AG, Rol N, Szulcek R, Dos Remedios C, Guignabert C, Tu L, Dorfmüller P, Humbert M, Wijnker PJM, Kuster DWD, van der Velden J, Goumans MJ, Bogaard HJ, Vonk-Noordegraaf A, de Man FS, Handoko ML.

Circulation. 2018 Feb 27;137(9):910-924. doi: 10.1161/CIRCULATIONAHA.117.027451. Epub 2017 Nov 22.

PMID:
29167228
18.

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.

Nossent EJ, Antigny F, Montani D, Bogaard HJ, Ghigna MR, Lambert M, Thomas de Montpréville V, Girerd B, Jaïs X, Savale L, Mercier O, Fadel E, Soubrier F, Sitbon O, Simonneau G, Vonk Noordegraaf A, Humbert M, Perros F, Dorfmüller P.

J Heart Lung Transplant. 2018 May;37(5):647-655. doi: 10.1016/j.healun.2017.09.022. Epub 2017 Oct 4.

PMID:
29108819
19.

Levosimendan improves cardiac function and myocardial efficiency in rats with right ventricular failure.

Hansen MS, Andersen A, Tolbod LP, Hansson NH, Nielsen R, Vonk-Noordegraaf A, Nielsen-Kudsk JE.

Pulm Circ. 2018 Jan-Mar;8(1):2045893217743122. doi: 10.1177/2045893217743122. Epub 2017 Nov 3.

20.

Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.

da Silva Gonçalves Bos D, Happé C, Schalij I, Pijacka W, Paton JFR, Guignabert C, Tu L, Thuillet R, Bogaard HJ, van Rossum AC, Vonk-Noordegraaf A, de Man FS, Handoko ML.

JACC Basic Transl Sci. 2017 Feb 1;2(1):22-35. doi: 10.1016/j.jacbts.2016.09.007. eCollection 2017 Feb.

21.

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Hadinnapola C, Bleda M, Haimel M, Screaton N, Swift A, Dorfmüller P, Preston SD, Southwood M, Hernandez-Sanchez J, Martin J, Treacy C, Yates K, Bogaard H, Church C, Coghlan G, Condliffe R, Corris PA, Gibbs S, Girerd B, Holden S, Humbert M, Kiely DG, Lawrie A, Machado R, MacKenzie Ross R, Moledina S, Montani D, Newnham M, Peacock A, Pepke-Zaba J, Rayner-Matthews P, Shamardina O, Soubrier F, Southgate L, Suntharalingam J, Toshner M, Trembath R, Vonk Noordegraaf A, Wilkins MR, Wort SJ, Wharton J; NIHR BioResource–Rare Diseases Consortium; UK National Cohort Study of Idiopathic and Heritable PAH, Gräf S, Morrell NW.

Circulation. 2017 Nov 21;136(21):2022-2033. doi: 10.1161/CIRCULATIONAHA.117.028351. Epub 2017 Sep 28.

22.

Treatment strategies for the right heart in pulmonary hypertension.

Westerhof BE, Saouti N, van der Laarse WJ, Westerhof N, Vonk Noordegraaf A.

Cardiovasc Res. 2017 Oct 1;113(12):1465-1473. doi: 10.1093/cvr/cvx148. Review.

23.

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy.

Bhansing KJ, Vonk-Noordegraaf A, Oosterveer FP, van Riel PL, Vonk MC.

RMD Open. 2017 Jun 9;3(1):e000331. doi: 10.1136/rmdopen-2016-000331. eCollection 2017.

24.

Vascular remodelling in the pulmonary circulation after major lung resection.

Rol N, Happé C, Beliën JAM, de Man FS, Westerhof N, Vonk-Noordegraaf A, Grünberg K, Bogaard HJ.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700806. doi: 10.1183/13993003.00806-2017. Print 2017 Aug. No abstract available.

PMID:
28860267
25.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E.

Eur Respir J. 2017 Aug 3;50(2). pii: 1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug.

PMID:
28775047
26.

Is there a vanishing pulmonary capillary syndrome?

Hoeper MM, Vonk-Noordegraaf A.

Lancet Respir Med. 2017 Sep;5(9):676-678. doi: 10.1016/S2213-2600(17)30291-6. Epub 2017 Jul 19. No abstract available.

PMID:
28734824
27.

Upfront combination therapy reduces right ventricular volumes in pulmonary arterial hypertension.

van de Veerdonk MC, Huis In T Veld AE, Marcus JT, Westerhof N, Heymans MW, Bogaard HJ, Vonk-Noordegraaf A.

Eur Respir J. 2017 Jun 29;49(6). pii: 1700007. doi: 10.1183/13993003.00007-2017. Print 2017 Jun.

PMID:
28663315
28.

Pulmonary hypertension with warm hands.

Botros L, Aman J, Bogaard HJ, Vonk Noordegraaf A.

Thorax. 2017 Dec;72(12):1164-1166. doi: 10.1136/thoraxjnl-2017-209982. Epub 2017 May 5. No abstract available.

29.

Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension†.

Gorter TM, Verschuuren EAM, van Veldhuisen DJ, Hoendermis ES, Erasmus ME, Bogaard HJ, Vonk Noordegraaf A, Berger RMF, van Melle JP, Willems TP.

Interact Cardiovasc Thorac Surg. 2017 Jun 1;24(6):890-897. doi: 10.1093/icvts/ivx025.

PMID:
28329267
30.

Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance.

Rol N, Timmer EM, Faes TJ, Vonk Noordegraaf A, Grünberg K, Bogaard HJ, Westerhof N.

Physiol Rep. 2017 Mar;5(6). pii: e13159. doi: 10.14814/phy2.13159.

31.

Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.

Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, Huisman MV, Klok FA.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601792. doi: 10.1183/13993003.01792-2016. Print 2017 Feb.

32.

A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia.

Paff T, Daniels JM, Weersink EJ, Lutter R, Vonk Noordegraaf A, Haarman EG.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601770. doi: 10.1183/13993003.01770-2016. Print 2017 Feb.

33.

Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience.

Sitbon O, Vonk Noordegraaf A.

Eur Respir Rev. 2017 Jan 17;26(143). pii: 160055. doi: 10.1183/16000617.0055-2016. Print 2017 Jan. Review.

34.

The Relationship Between the Right Ventricle and its Load in Pulmonary Hypertension.

Vonk Noordegraaf A, Westerhof BE, Westerhof N.

J Am Coll Cardiol. 2017 Jan 17;69(2):236-243. doi: 10.1016/j.jacc.2016.10.047. Review.

35.

Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research.

Hoeper MM, Lam CSP, Vachiery JL, Bauersachs J, Gerges C, Lang IM, Bonderman D, Olsson KM, Gibbs JSR, Dorfmuller P, Guazzi M, Galiè N, Manes A, Handoko ML, Vonk-Noordegraaf A, Lankeit M, Konstantinides S, Wachter R, Opitz C, Rosenkranz S.

Eur Heart J. 2017 Oct 7;38(38):2869-2873. doi: 10.1093/eurheartj/ehw597. No abstract available.

PMID:
28011705
36.

A critical appraisal of transpulmonary and diastolic pressure gradients.

Handoko ML, De Man FS, Oosterveer FP, Bogaard HJ, Vonk-Noordegraaf A, Westerhof N.

Physiol Rep. 2016 Sep;4(17). pii: e12910. doi: 10.14814/phy2.12910.

37.

CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension.

Huis In 't Veld AE, Van Vliet AG, Spruijt OA, Handoko ML, Marcus JT, Vonk Noordegraaf A, Bogaard HJ.

Int J Cardiol. 2016 Nov 15;223:723-728. doi: 10.1016/j.ijcard.2016.08.314. Epub 2016 Aug 22.

PMID:
27573596
38.

Response by van der Bruggen et al to Letter Regarding Article, "Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle".

van der Bruggen CE, Happé CM, Goumans MJ, Bogaard HJ, Vonk Noordegraaf A, de Man FS.

Circulation. 2016 Aug 30;134(9):e117-8. doi: 10.1161/CIRCULATIONAHA.116.024173. No abstract available.

PMID:
27572883
39.

The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension.

Lang IM, Dorfmüller P, Vonk Noordegraaf A.

Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S215-21. doi: 10.1513/AnnalsATS.201509-620AS. Review.

PMID:
27571003
40.

The Real Face of Borderline Pulmonary Hypertension in Connective Tissue Disease.

van der Bruggen CE, Nossent EJ, Grünberg K, Bogaard HJ, Vonk Noordegraaf A.

Ann Am Thorac Soc. 2016 Aug;13(8):1428-30. doi: 10.1513/AnnalsATS.201604-275LE. No abstract available.

PMID:
27509159
41.

Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study.

van Campen JS, de Boer K, van de Veerdonk MC, van der Bruggen CE, Allaart CP, Raijmakers PG, Heymans MW, Marcus JT, Harms HJ, Handoko ML, de Man FS, Vonk Noordegraaf A, Bogaard HJ.

Eur Respir J. 2016 Sep;48(3):787-96. doi: 10.1183/13993003.00090-2016. Epub 2016 Jul 7.

42.

Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril Stiffness.

Rain S, Andersen S, Najafi A, Gammelgaard Schultz J, da Silva Gonçalves Bós D, Handoko ML, Bogaard HJ, Vonk-Noordegraaf A, Andersen A, van der Velden J, Ottenheijm CA, de Man FS.

Circ Heart Fail. 2016 Jul;9(7). pii: e002636. doi: 10.1161/CIRCHEARTFAILURE.115.002636.

43.

Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

de Raaf MA, Herrmann FE, Schalij I, de Man FS, Vonk-Noordegraaf A, Guignabert C, Wollin L, Bogaard HJ.

Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H604-12. doi: 10.1152/ajpheart.00656.2015. Epub 2016 Jun 24.

44.

Why vessels do matter in pulmonary disease.

Aman J, Bogaard HJ, Vonk Noordegraaf A.

Thorax. 2016 Aug;71(8):767-9. doi: 10.1136/thoraxjnl-2016-208853. Epub 2016 Jun 20. No abstract available.

PMID:
27325753
45.

Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertension.

Manders E, Bonta PI, Kloek JJ, Symersky P, Bogaard HJ, Hooijman PE, Jasper JR, Malik FI, Stienen GJ, Vonk-Noordegraaf A, de Man FS, Ottenheijm CA.

Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L20-8. doi: 10.1152/ajplung.00113.2016. Epub 2016 May 17.

46.

A modified Delphi method toward multidisciplinary consensus on functional convalescence recommendations after abdominal surgery.

van Vliet DC, van der Meij E, Bouwsma EV, Vonk Noordegraaf A, van den Heuvel B, Meijerink WJ, van Baal WM, Huirne JA, Anema JR.

Surg Endosc. 2016 Dec;30(12):5583-5595. Epub 2016 May 2.

47.

Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.

Happé CM, de Raaf MA, Rol N, Schalij I, Vonk-Noordegraaf A, Westerhof N, Voelkel NF, de Man FS, Bogaard HJ.

Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1088-97. doi: 10.1152/ajplung.00023.2016. Epub 2016 Apr 1.

48.

Serial assessment of right ventricular systolic function in patients with precapillary pulmonary hypertension using simple echocardiographic parameters: A comparison with cardiac magnetic resonance imaging.

Spruijt OA, Di Pasqua MC, Bogaard HJ, van der Bruggen CE, Oosterveer F, Marcus JT, Vonk-Noordegraaf A, Handoko ML.

J Cardiol. 2017 Jan;69(1):182-188. doi: 10.1016/j.jjcc.2016.02.019. Epub 2016 Mar 22.

49.

Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.

van der Bruggen CE, Happé CM, Dorfmüller P, Trip P, Spruijt OA, Rol N, Hoevenaars FP, Houweling AC, Girerd B, Marcus JT, Mercier O, Humbert M, Handoko ML, van der Velden J, Vonk Noordegraaf A, Bogaard HJ, Goumans MJ, de Man FS.

Circulation. 2016 May 3;133(18):1747-60. doi: 10.1161/CIRCULATIONAHA.115.020696. Epub 2016 Mar 16.

PMID:
26984938
50.

Hypertension: Surgery remains treatment of choice for CTEPH.

Vonk Noordegraaf A, Bogaard HJ.

Nat Rev Cardiol. 2016 Apr;13(4):188-9. doi: 10.1038/nrcardio.2016.30. Epub 2016 Mar 10.

PMID:
26961067

Supplemental Content

Loading ...
Support Center